1 May 2023 - PHARMAC has announced an amendment to the Pharmaceutical Schedule from 1 June 2023, to align funding rules for ADHD treatments with law changes that enable controlled drugs to be prescribed for a maximum of three-months supply when using the New Zealand Electronic Prescription Service.